MTAP and thymic carcinoma: Recently, researchers of the Mayo Clinic (Rochester, MN, USA) used a panel of CD117, BAP1, mTAP and TdT in a series of 81 TETs including 44 thymomas and 37 thymic carcinomas and concluded that this panel could be useful to distinguish thymomas from thymic carcinomas [12].